KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilent Technologies (A) EBT (2016 - 2026)

Agilent Technologies (A) has disclosed EBT for 17 consecutive years, with $364.0 million as the latest value for Q1 2026.

  • On a quarterly basis, EBT fell 0.82% to $364.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $1.4 billion, a 3.57% decrease, with the full-year FY2025 number at $1.4 billion, down 5.65% from a year prior.
  • EBT was $364.0 million for Q1 2026 at Agilent Technologies, down from $442.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $455.0 million in Q4 2022 to a low of $132.0 million in Q3 2023.
  • A 5-year average of $362.5 million and a median of $374.0 million in 2024 define the central range for EBT.
  • Peak YoY movement for EBT: crashed 66.75% in 2023, then skyrocketed 159.85% in 2024.
  • Agilent Technologies' EBT stood at $455.0 million in 2022, then fell by 7.69% to $420.0 million in 2023, then dropped by 4.52% to $401.0 million in 2024, then rose by 10.22% to $442.0 million in 2025, then dropped by 17.65% to $364.0 million in 2026.
  • Per Business Quant, the three most recent readings for A's EBT are $364.0 million (Q1 2026), $442.0 million (Q4 2025), and $366.0 million (Q3 2025).